Efficacy of catheter ablation of atrial fibrillation beyond HATCH score

Chinese Medical Journal

Volumn 125, Issue 19, 2012, Pages 3425-3429

  Tang, Ri bo ^a   Dong, Jian zeng ^a   Long, De yong ^a   Yu, Rong hui ^a   Ning, Man ^a   Jiang, Chen xi ^a   Sang, Cai hua ^a   Liu, Xiao hui ^a   Ma, Chang sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; HATCH score

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; BODY MASS; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HATCH SCORE; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; CATHETER ABLATION; ELECTROPHYSIOLOGY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED;

EID: 84867425251     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.19.012     Document Type: Article

References (22)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
3. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
4. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010; 55: 725-731.
5. Tang RB, Dong JZ, Zhao WD, Liu XP, Kang JP, Long DY, et al. Unconscious sedation/analgesia with propofol versus conscious sedation with fentanyl/midazolam for catheter ablation of atrial fibrillation: a prospective, randomized study. Chin Med J 2007; 120: 2036-2038.
6. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fribrillation after circumferential pulmonary vein ablation: What's the difference? Chin Med J 2005; 118: 1773-1778.
7. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009; 73: 438-443.
8. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383.
9. Zado E, Callans DJ, Riley M, Hutchinson M, Garcia F, Bala R, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 2008; 19: 621-626.
10. Tang RB, Liu DL, Dong JZ, Liu XP, Long DY, Yu RH, et al. High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2010; 74: 1316-1321.
11. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
12. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861.
13. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT, et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: lessons from double Lasso technique. Circulation 2005; 111: 127-135.
14. Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, Levy D, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009; 104: 92-96.
15. Shimano M, Tsuji Y, Inden Y, Kitamura K, Uchikawa T, Harata S, et al. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart Rhythm 2008; 5: 451-459.
16. Hagiwara N. Inflammation and atrial fibrillation. Circ J 2010; 74: 246-247.
17. Hwang HJ, Ha JW, Joung B, Choi EH, Kim J, Ahn MS, et al. Relation of inflammation and left atrial remodeling in atrial fibrillation occurring in early phase of acute myocardial infarction. Int J Cardiol 2011; 146: 28-31.
18. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51: 828-835.
19. Liakopoulos OJ, Choi YH, Kuhn EW, Wittwer T, Borys M, Madershahian N, et al. Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review. J Thorac Cardiovasc Surg 2009; 138: 678-686.
20. Park JH, Oh YS, Kim JH, Chung WB, Oh SS, Lee DH, et al. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on patients following ablation of atrial fibrillation. Korean Circ J 2009; 39: 185-189.
21. Richter B, Derntl M, Marx M, Lercher P, Gossinger HD. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am Heart J 2007; 153: 113-119.
22. Al-Chekakie MO, Akar JG, Wang F, Al Muradi H, Wu J, Santucci P, et al. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol 2007; 18: 942-946.